Clozapine Interrupted: APA, Others Seek FDA Forum on REMS

Seven psychiatric groups are calling for the FDA to hold a public advisory committee meeting about its risk evaluation and mitigation strategy (REMS) for the schizophrenia drug clozapine.
Medscape Medical News
Seven psychiatric groups are calling for the FDA to hold a public advisory committee meeting about its risk evaluation and mitigation strategy (REMS) for the schizophrenia drug clozapine.
Medscape Medical News